Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immune Monitoring to Facilitate Belatacept Monotherapy

NCT04177095 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04177095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04177095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immune Monitoring to Facilitate Belatacept Monotherapy
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Completed
Start date
February 11, 2020
Completion date
June 1, 2023
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunosuppression, kidney transplant rejection